Cargando…

Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report

Transarterial chemoembolization (TACE) is frequently used for treatment of unresectable hepatocellular carcinoma (HCC) and can also be used for case of liver metastases from rectal cancer. Although it is recognized as safe and effective treatment, various complications have been reported. However, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Shin Il, Jin, Young-Joo, Cho, Soon Gu, Shin, Woo Young, Kim, Joon Mee, Lee, Jin-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058803/ https://www.ncbi.nlm.nih.gov/pubmed/27399074 http://dx.doi.org/10.1097/MD.0000000000003987

Ejemplares similares

Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma
por: Suh, Young Ju, et al.
Publicado: (2021)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

Expression of Phosphorylated AMP-Activated Protein Kinase Predicts Response to Transarterial Chemoembolization in Postoperative Cases of Hepatocellular Carcinoma
por: Zheng, Long-Yi, et al.
Publicado: (2016)

Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors
por: Gao, Zhendong, et al.
Publicado: (2017)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Tang, Chengwu, et al.
Publicado: (2016)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria: A propensity score matching analysis
por: Guo, Zhe, et al.
Publicado: (2017)

Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma
por: Deng, Jun, et al.
Publicado: (2021)

Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2021)

Hepatic Resection for Hepatocellular Carcinoma in Patients With Portal Hypertension: A Long-Term Benefit Compared With Transarterial Chemoembolization and Thermal Ablation
por: Xiao, Hua, et al.
Publicado: (2015)

Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs
por: Lee, Seung Ho, et al.
Publicado: (2017)

Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan
por: Tseng, Chi-Lung, et al.
Publicado: (2015)

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
por: Jang, Ji Hye, et al.
Publicado: (2015)

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019)

Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma
por: Nouri, Yasir M., et al.
Publicado: (2019)

Survival benefit of radiofrequency ablation for solitary (3–5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry
por: Lee, Seung Ho, et al.
Publicado: (2017)

Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance
por: Jang, Sangmi, et al.
Publicado: (2023)

Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
por: Lim, Jung Hyun, et al.
Publicado: (2021)

Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Park, Chan, et al.
Publicado: (2021)

Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Kim, Young Woon, et al.
Publicado: (2018)

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Jeong, Shin Ok, et al.
Publicado: (2017)

Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease
por: Lin, Wei-Chen, et al.
Publicado: (2019)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
por: Park, Kil Hyo, et al.
Publicado: (2015)

A prospective randomized noninferiority trial comparing conventional smears and SurePath(TM) liquid-based cytology in endoscopic ultrasound-guided sampling of esophageal, gastric, and duodenal lesions
por: Jun, Jae Chang, et al.
Publicado: (2023)

The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients
por: Kim, Hwi Young, et al.
Publicado: (2016)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Endoscopic treatment for duodenal perforation due to biliary stent dislocation: A case report and brief review of the literature
por: Fujii, Yuki, et al.
Publicado: (2022)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Sohn, Won, et al.
Publicado: (2020)

Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report
por: Roehlen, Natascha, et al.
Publicado: (2018)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
por: Woo, Hyun Young, et al.
Publicado: (2015)

Esophageal Involvement of Immunoglobulin G4-Related Disease: A Case Report and Literature Review
por: Oh, Ji Hyun, et al.
Publicado: (2015)

Colonic diverticular perforation by a migrated biliary stent: A case report with literature review
por: Park, Tae Young, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization
por: Liu, Chang, et al.
Publicado: (2017)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_e6os5a7o8ftcnq7skn6i4agdp2